Free tool
Stocks listed on London
We cover 39 companies listed on London. The median market value in the group is $28.91M. Across the group, the median move over the past trading day is 0.00%. 33% of the 39 with a 200-day average trade above it. Price change over the past year runs from −73.3% to +82.5% across the middle 80 percent of the group, with a median of −22.4%.
Other lists in this group
Table
39 of 3,049 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| SN.L | Smith & Nephew plc | $12.18B | Large cap | −22.42% |
| 4BB.L | 4basebio PLC | $99.96M | Micro cap | −46.89% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| CREO.L | Creo Medical Group PLC | $85.82M | Micro cap | −1.90% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| OBI.L | Ondine Biomedical Inc. | $81.20M | Micro cap | −24.19% |
| KOO.L | Kooth plc | $72.00M | Micro cap | −7.59% |
| STX.L | Shield Therapeutics plc | $71.97M | Micro cap | −37.42% |
| HVO.L | hVIVO plc | $59.87M | Micro cap | −35.00% |
| BVC.L | BATM Advanced Communications Ltd. | $54.53M | Micro cap | −21.90% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $54.52M | Micro cap | +70.43% |
| COIL.L | Coiled Therapeutics plc | $49.30M | Micro cap | −26.92% |
| MPAL.L | MedPal AI PLC | $44.20M | Micro cap | −40.00% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| PXS.L | Provexis plc | $32.52M | Micro cap | +51.39% |
| IMM.L | ImmuPharma plc | $31.75M | Micro cap | +89.66% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| IXI.L | IXICO plc | $23.06M | Micro cap | −36.73% |
| IHC.L | Inspiration Healthcare Group plc | $22.54M | Micro cap | −19.74% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| FAB.L | Fusion Antibodies plc | $19.13M | Micro cap | −23.73% |
| THAT.L | Thalia Therapeutics Plc | $15.69M | Micro cap | +52.94% |
| GENF.L | Genflow Biosciences plc | $15.39M | Micro cap | +166.67% |
| APTA.L | Aptamer Group PLC | $15.32M | Micro cap | −62.50% |
| SVNS.L | Solvonis Therapeutics plc | $11.56M | Micro cap | −55.64% |
| GENI.L | GENinCode Plc | $9.25M | Micro cap | −35.71% |
| OPTI.L | OptiBiotix Health Plc | $7.93M | Micro cap | −51.91% |
| PRM.L | Proteome Sciences plc | $7.53M | Micro cap | −44.39% |
| OBD.L | Oxford BioDynamics Plc | $6.85M | Micro cap | −74.11% |
| NFX.L | Nuformix plc | $5.85M | Micro cap | +80.68% |
| PYC.L | Physiomics Plc | $3.17M | Micro cap | +21.18% |
| FUM.L | Futura Medical plc | $3.16M | Micro cap | −95.67% |
| BSFA.L | BSF Enterprise Plc | $3.03M | Micro cap | −48.89% |
| VAL.L | ValiRx plc | $2.78M | Micro cap | −73.04% |
| IBAI.L | Imaging Biometrics Ltd. | $2.35M | Micro cap | +2.42% |
| TRLS.L | Trellus Health plc | $701.41K | Micro cap | −94.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.